Not All Keto Diets Are Equal: Saturated Long-Chain Fats May Drive Inflammation

Not all ketogenic diets are the same; the fat may decide the outcome
Cincinnati researchers say the type of fat in a keto diet may shape whether inflammation rises.
Mark

So what's the basic finding here?

Mimi

That 'keto' isn't one diet. When the fat came mostly from long-chain saturated fatty acids, inflammation rose. Unsaturated and medium-chain fats leaned anti-inflammatory.

Mark

Why does that matter for the earlier contradictory studies?

Mimi

Some found keto calmed inflammation and others found it raised it. Gius's team suggests the type of fat may be one reason for those divergent outcomes.

Luke

'May be one reason' is doing real work there. Did this study show that explains the earlier contradictions?

Mimi

No. It identifies a plausible contributing factor. It doesn't reconcile every prior study.

Mark

What's the mechanism?

Mimi

Mitochondrial stress signaling and activation of immune cells, according to the researchers.

Luke

And the subjects were mice and tissue cultures. Nothing here says a person eating saturated-fat keto will see the same inflammation.

Mimi

Right. Human trials would be needed before anyone changes guidance.

Mark

Was this what they were looking for?

Mimi

Gius says it was unexpected. They were studying something else and followed the data.

Luke

Worth noting the source gives no numbers on effect size, so we can't judge how large the difference was.

  • Ketogenic diets have produced contradictory findings, with some studies showing calmer inflammation and others showing harm.
  • A University of Cincinnati team reports that long-chain saturated fats pushed mice and cells toward an inflammatory immune response.
  • Unsaturated and medium-chain fats appeared to favor anti-inflammatory effects, turning the diet's outcome on its fat source.
  • The mechanism runs through mitochondrial stress signaling and the activation of immune cells, now under closer study.
  • Everything so far comes from animal and cell models, so human trials must confirm the pattern before any dietary advice shifts.

Every so often a study arrives that does not simply add another data point but offers a reason why the existing ones disagree. Researchers at the University of Cincinnati Cancer Center, led by David Gius, suggest that ketogenic diets have produced conflicting results because they are not all the same: the kind of fat carried in the diet appears to decide whether the body's inflammatory response is calmed or inflamed. The work, published in Science Advances, rests on mice and cell cultures rather than people, so it reads less as a verdict than as a careful clue that the plate's fat deserves as much attention as the carbohydrates it replaces.

A study published on November 13 in Science Advances offers a possible reason why ketogenic diets have yielded such mixed results. Some research has found that the high-fat, low-carbohydrate approach calms inflammation, while other work has found the opposite, along with other harms. A team at the University of Cincinnati Cancer Center now points to the type of fat on the plate.

The work was led by David Gius, director of the Cancer Center, who said the finding was not the original goal. The team had been studying another aspect of ketogenic diets when the data pointed somewhere unexpected, and they followed it. Earlier studies from the group had already shown that different fats produce different metabolic changes.

To test this, the researchers fed mice diets built from different fatty acids and applied individual fats to tissue cultures, comparing effects in whole animals and in cells. The results split along the chemistry of the fat. Long-chain saturated fats favored inflammatory immune responses, driven by mitochondrial stress signaling and immune cell activation. Unsaturated and medium-chain fats tended toward anti-inflammatory effects.

The evidence comes from mice and cells, not people, and such findings generally need human trials before they change dietary guidance. For now, the study suggests the fat in a ketogenic diet may matter as much as the carbohydrates it leaves out.

A study published on November 13 in the journal Science Advances gives a possible explanation for why ketogenic diets have produced such mixed results in research. Some studies have found that the high-fat, low-carbohydrate approach calms inflammation. Others have found the opposite, along with other harmful effects. A team at the University of Cincinnati Cancer Center now points to the kind of fat on the plate.

The work was led by David Gius, MD, PhD, director of the Cancer Center. He is also a professor in the Department of Radiation Oncology in the UC College of Medicine and a UC Health physician. By his account, the finding was not what the team set out to look for. They were studying a different aspect of ketogenic diets when the data pointed somewhere unexpected, and they followed it.

A ketogenic diet aims to push the body into ketosis. In that metabolic state, it burns fat and ketones for fuel instead of glucose. The diet's name describes the goal, but not the ingredients, and that is the gap this research addresses. Gius said the group's earlier studies had already shown that ketogenic diets are not all alike, because different fats cause different metabolic changes.

To test that, the researchers fed mice ketogenic diets built from different fatty acids. They also applied individual fatty acids to tissue culture models. This let them compare the effects of specific fats, both in whole animals and in cells.

The results split along the chemistry of the fat. Long-chain saturated fatty acids appeared to favor an inflammatory immune response. Unsaturated and medium-chain fatty acids tended to favor anti-inflammatory characteristics. The team found that the increase in inflammation was mediated through mitochondrial stress signaling and the activation of immune cells.

The paper builds on two earlier publications from the same group, one in Science Advances in 2024 and one in Cell Reports in 2025. Taken together, the three suggest that several factors may need attention to get the intended result from a ketogenic diet. The dietary source of fat is one of them.

The evidence so far comes from mice and cell cultures, not people. Findings at that stage generally need testing in human trials before they change dietary guidance, and the source describes no such trials. For now, the study is a signal that the fat in a ketogenic diet may matter as much as the carbohydrates left out of it.

Long-chain saturated fatty acids seem to favor an inflammatory immune response, whereas unsaturated and medium-chain fatty acids tend to favor anti-inflammatory characteristics.
— David Gius, MD, PhD, University of Cincinnati Cancer Center
Quieres la nota completa? Lee el original en News-Medical ↗
Contáctanos FAQ